World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
119
Citations
54291
World Ranking
3888
National Ranking
152

Overview

Rudolf A. de Boer is affiliated with the University Medical Center Groningen in the Netherlands and has a significant body of work in medicine, particularly in cardiology and cardiovascular medicine. Their research spans multiple subfields including cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, molecular biology, surgery, and oncology.

The scientist's main research topics cover a wide range of areas related to cardiovascular and metabolic health. These topics include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Cardiomyopathy and Myosin Studies
  • Pancreatic function and diabetes
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies

Rudolf A. de Boer has been published extensively in several key scientific venues, including:

  • European Journal of Heart Failure
  • European Heart Journal
  • Circulation
  • JACC Heart Failure
  • Journal of the American College of Cardiology

Their recent papers reflect ongoing contributions to cardiovascular research and clinical guidelines. Notable recent publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2021, European Heart Journal)
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022, New England Journal of Medicine)
  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) (2022, European Heart Journal)
  • 2023 ESC Guidelines for the management of cardiomyopathies (2023, European Heart Journal)
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2023, European Heart Journal)

Throughout their career, Rudolf A. de Boer has frequently collaborated with several other researchers. Regular co-authors include:

  • John J.V. McMurray
  • Pardeep S. Jhund
  • Scott D. Solomon
  • Felipe A. Martínez
  • Carolyn S.P. Lam

Overall, Rudolf A. de Boer's publication record and collaborative network indicate a sustained focus on clinical and translational research in cardiovascular disease and related metabolic disorders. Their work is characterized by engagement in guideline development, clinical trials, and studies addressing mechanisms and treatment strategies in heart failure and associated conditions.

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    Burkert Pieske;Carsten Tschöpe;Rudolf A de Boer;Alan G Fraser

  • Identification of seven loci affecting mean telomere length and their association with disease

    Veryan Codd;Christopher P Nelson;Eva Albrecht;Massimo Mangino

  • Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

    Rudolf A de Boer;Dirk J A Lok;Tiny Jaarsma;Peter O van der Meer

  • Galectin-3: a novel mediator of heart failure development and progression.

    Rudolf A. de Boer;Adriaan A. Voors;Pieter Muntendam;Wiek H. van Gilst

  • Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

    Frank P. Brouwers;Rudolf A. de Boer;Pim van der Harst;Adriaan A. Voors

  • Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

    Petar M. Seferović;Mark C. Petrie;Gerasimos S. Filippatos;Stefan D. Anker

  • Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology

    Petar M Seferovic;Piotr Ponikowski;Stefan D Anker;Johann Bauersachs

  • Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

    Christian Mueller;Kenneth McDonald;Rudolf A. de Boer;Alan Maisel

  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

    Alexander R. Lyon;Susan Dent;Susannah Stanway;Helena Earl

  • Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

    Sheryl L. Chow;Alan S. Maisel;Inder Anand;Biykem Bozkurt

  • Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

    Ronald P. Stolk;Judith G. M. Rosmalen;Dirkje S. Postma;Rudolf A. de Boer

  • Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

    Lili Yu;Willem P.T. Ruifrok;Maxi Meissner;Eelke M. Bos

  • Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy

    Paul A. van der Zwaag;Ingrid A. W. van Rijsingen;Angeliki Asimaki;Jan D. H. Jongbloed

  • New gene functions in megakaryopoiesis and platelet formation

    Christian Gieger;Aparna Radhakrishnan;Ana Cvejic;Weihong Tang

  • The fibrosis marker galectin-3 and outcome in the general population.

    R. A. de Boer;D. J. van Veldhuisen;R. T. Gansevoort;A. C. Muller Kobold

  • Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

    Laurent Calvier;Maria Miana;Pascal Reboul;Victoria Cachofeiro

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

  • Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

    Karani S Vimaleswaran;Karani S Vimaleswaran;Alana Cavadino;Diane J Berry;Rolf Jorde

  • Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.

    Nona Sotoodehnia;Aaron Isaacs;Paul I W de Bakker;Marcus Dörr

Frequent Co-Authors

Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Wiek H. van Gilst
Wiek H. van Gilst University Medical Center Groningen
Pim van der Harst
Pim van der Harst University Medical Center Utrecht
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Hans L. Hillege
Hans L. Hillege University Medical Center Groningen
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Peter van der Meer
Peter van der Meer University Medical Center Groningen
Stephan J. L. Bakker
Stephan J. L. Bakker University Medical Center Groningen
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t just mean medical school. There’s a diverse range of online healthcare degrees available, opening doors to administrative, nursing, and leadership roles. Flexible online options are increasingly popular, especially for professionals balancing work, study, and family obligations.

For those interested in healthcare management, consider online MHA programs that hold prestigious CAHME accreditation. Registered Nurses wanting to further their education can enroll in online RN to BSN programs without clinicals. These programs offer a streamlined path to a higher degree without additional hands-on training requirements.

If your goal is to advance clinical expertise, there are both quickest DNP program options and easiest online DNP programs available entirely online. These programs allow you to elevate your practice with greater flexibility and potentially faster completion times.

Whether you seek direct patient care or leadership in healthcare systems, these online pathways can help you reach your goals and adapt to a rapidly changing industry.

Best Scientists Citing Rudolf A. de Boer

Trending Scientists

Recently Published Articles